medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 5

<< Back Next >>

Acta Pediatr Mex 2018; 39 (5)

Association between serum lactate dehydrogenase levels in the first 12 hours of life and the development of hypoxicischemic encephalopathy. A preliminary study

Patrón-Chí SA, Peraza-López EE, Zapata-Peraza AL
Full text How to cite this article

Language: Spanish
References: 29
Page: 271-282
PDF size: 453.24 Kb.


Key words:

Hypoxic-ischemic encephalopathy, Perinatal asphyxia, Lactate dehydrogenase, Asphyxia.

ABSTRACT

Introduction: Hypoxic-ischemic encephalopathy is the most severe consequence of perinatal asphyxia. The rate of change in the serum levels of some intracellular enzymes among the first hours of extrauterine life may serve as indication of heighten risk for the development of Hypoxic-ischemic encephalopathy.
Objective: To analyze the possible association between the rates of change in serum lactate dehydrogenase values in the first 12 hours of extrauterine life and the development of hypoxic-ischemic encephalopathy.
Methods: Diagnostic test study. Lactate dehydrogenase determinations were performed at 0, 6 and 12 hours of extrauterine life in neonates who presented clinical diagnosis of perinatal asphyxia (n = 10) and in patients with risk factors that did not meet asphyxia criteria (n = 10).
Results: Setting a cut-off point for serum lactate dehydrogenase at 775 IU/L, a sensitivity of 90% and specificity of 60% for the development of hypoxic-ischemic encephalopathy was obtained. An increase for serum values of lactate dehydrogenase equal to or greater than 0.33%/hour between 0 and 12 hours showed sensitivity of 90% and specificity 100% with respect to the development of hypoxic-ischemic encephalopathy.
Conclusion: Variation in serum lactate dehydrogenase levels in the first 12 hours of life is associated with the development of hypoxic-ischemic encephalopathy.


REFERENCES

  1. Beken S, Aydın B, Dilli D, Erol S, Zenciroğlu A, Okumuş N. Can biochemical markers predict the severity of hypoxic-ischemic encephalopathy? Turk J Pediatr. 2014 Feb;56(1):62-8.

  2. Antonucci R, Porcella A, Pilloni MD. Perinatal asphyxia in the term newborn. J Pediatr Neonatal Individ Med JPNIM. 2014 Oct 21;3(2): e030269.

  3. Nelson KB, Leviton A. How much of neonatal encephalopathy is due to birth asphyxia? Am J Dis Child 1960. 1991 Nov;145(11):1325-31.

  4. Lawn JE, et al. Four million neonatal deaths: counting and attribution of cause of death. Paediatr Perinat Epidemiol. 2008 Sep;22(5):410-6. https://doi.org/10.1111/j.1365- 3016.2008.00960.x

  5. García-Alix A, et al. Neonatal hypoxic-ischemic encephalopathy: Incidence and prevalence in the first decade of the 21st century. An Pediatr Barc Spain 2003. 2009 Oct;71(4):319-26. DOI: 10.1016/j.anpedi.2009.07.021

  6. Hayakawa M, et al. Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan. Pediatr Int Off J Jpn Pediatr Soc. 2014 Apr;56(2):215-21. https://doi. org/10.1111/ped.12233

  7. Bryce J, et al. WHO estimates of the causes of death in children. Lancet Lond Engl. 2005 Apr 26;365(9465):1147-52. https://doi.org/10.1016/S0140-6736(05)71877-8

  8. Lindström K, et al. Moderate neonatal encephalopathy: pre- and perinatal risk factors and long-term outcome. Obstetric Anesthesia Digest. 2008 Dec; 87(5):503-9. doi: 10.1097/01.aoa.0000337914.86125.54

  9. Fernández Cantón S, Hernández Martínez AM, Viguri Uribe R. Mortalidad de la población de menores de cinco años en México durante 2011. Bol Med Hosp Infant Mex. 2013;70(1):66-69.

  10. Castañeda-Casale G, Márquez-González H, Rodríguez- Reyes ER. Mortalidad perinatal en un hospital de segundo nivel de atención. Rev Med Inst Mex Seguro Soc. 2010;48(3):237-42.

  11. Sierra MTM, Lozano R, Santos JI. Mortalidad perinatal por asfixia en México: problema prioritario de salud pública por resolver. Bol Med Hosp Infant Mex. 2005;62(5):375-83.

  12. Nelson KB, Bingham P, Edwards EM, Horbar JD, Kenny MJ, Inder T, et al. Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry. Pediatrics. 2012 Nov;130(5):878-86.

  13. Martinez-Biarge M, Diez-Sebastian J, Wusthoff CJ, Mercuri E, Cowan FM. Antepartum and intrapartum factors preceding neonatal hypoxic-ischemic encephalopathy. Pediatrics. 2013 Oct;132(4): e952-959.

  14. Karlsson M, et al. Lactate dehydrogenase predicts hypoxic ischemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr Oslo Nor. 2010 Aug;99(8):1139-44. https://doi.org/10.1111/j.1651-2227.2010.01802.x

  15. Ramu D, Madapura.V P, Sabapathy S, Rajendra N. Study of dynamics of lactate dehydrogenase and hepatic enzymes activity following perinatal asphyxia in full term neonates. Pediatr Rev Int J Pediatr Res [Internet]. 2016 Sep 30 [cited 2018 Mar 1];3(09). http://medresearch.in/index.php/IJPR/ article/view/835

  16. Karlsson M, et al. Dynamics of hepatic enzyme activity following birth asphyxia. Acta Paediatr Oslo Nor 1992. 2006 Nov;95(11):1405-11. https://doi. org/10.1080/08035250600693488

  17. Magalhães M, Rodrigues FPM, Chopard MRT, Melo VC de A, Melhado A, Oliveira I, et al. Neuroprotective body hypothermia among newborns with hypoxic ischemic encephalopathy: three-year experience in a tertiary university hospital. A retrospective observational study. Sao Paulo Med J. 2015 Aug;133(4):314-9. http://dx.doi. org/10.1590/1516-3180.2013.7740026

  18. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009 Oct 1;361(14):1349-58. DOI: 10.1056/NEJMoa0900854

  19. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, Mc- Donald SA, Donovan EF, et al. Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy. N Engl J Med. 2005 Oct 13;353(15):1574-84. DOI: 10.1056/ NEJMcps050929

  20. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischemic encephalopathy: synthesis and meta-analysis of trial data. BMJ. 2010 Feb 9;340:c363. https://doi. org/10.1136/bmj.c363

  21. Karlsson M, Tooley JR, Satas S, Hobbs CE, Chakkarapani E, Stone J, et al. Delayed hypothermia as selective head cool ing or whole-body cooling does not protect brain or body in newborn pig subjected to hypoxia-ischemia. Pediatr Res. 2008 Jul;64(1):74-8.

  22. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischemic encephalopathy. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003311.

  23. Queensland Clinical Guidelines. Hypoxic-ischaemic encephalopathy (HIE). Australia: Queensland Health, 2017;1-26.

  24. Cruz-Cauich J, Lagunes-Cordoba R. El lactato en sangre como prueba diagnóstica de encefalopatía isquémica en neonatos. Rev Invest Cien Sal. 2012;7(2):22-8.

  25. Wiberg N, Källén K, Herbst A, Olofsson P. Relation between umbilical cord blood pH, base deficit, lactate, 5-minute Apgar score and development of hypoxic ischemic encephalopathy. Acta Obstet Gynecol Scand. 2010 Oct;89(10):1263-9.

  26. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003 Oct;125(4):1246-57.

  27. Mehmet H, Yue X, Penrice J, Cady E, Wyatt JC, Sarraf C, et al. Relation of impaired energy metabolism to apoptosis and necrosis following transient cerebral hypoxia-ischaemia. Cell Death Differ. 1998 Apr;5(4):321-9.

  28. Yue X, Mehmet H, Penrice J, Cooper C, Cady E, Wyatt JS, et al. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischaemia. Neuropathol Appl Neurobiol. 1997 Feb;23(1):16-25.

  29. Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Semin Neonatol SN. 2000 Feb;5(1):3-16.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2018;39